Shattuck Labs to Participate in Upcoming December Investor Conferences

Rhea-AI Summary

Shattuck Labs (NASDAQ: STTK) announced management will participate in multiple investor conferences in December 2025. CEO Taylor Schreiber, M.D., Ph.D. will present at the Piper Sandler 37th Annual Healthcare Conference on Dec 2, 2025 at 10:10 AM ET in New York and will take part in a fireside chat at the Evercore ISI 8th Annual HealthCONx Conference on Dec 4, 2025 at 8:20 AM ET in Coral Gables, plus one-on-one meetings on Dec 3–4. Webcast links will be provided and replays will be available on the company’s Events and Presentations page for up to 30 days after each presentation.

News Market Reaction

-1.53%

1 alert

-1.53% News Effect

On the day this news was published, STTK declined 1.53%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AUSTIN, TX and DURHAM, NC, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-mediated diseases, today announced that Company management will participate in multiple investor conferences in December 2025.

Conference Details

Conference: Piper Sandler 37^th Annual Healthcare Conference
Format: Presentation and one-on-one meetings
Presenter: Taylor Schreiber, M.D., Ph.D., Chief Executive Officer
Presentation Date: Dec 2, 2025
Time: 10:10 AM EST
Location: New York, NY
Webcast link: HERE

Conference: Evercore ISI 8^th Annual HealthCONx Conference
Format: Fireside chat with Umer Raffat and Jonathan Miller, Ph.D. and one-on-one meetings (Dec 3-4)
Presenter: Taylor Schreiber, M.D., Ph.D., Chief Executive Officer
Fireside Chat Date: Dec 4, 2025
Time: 8:20 AM EST
Location: Coral Gables, FL
Webcast link: HERE

A replay of the presentations from the Piper Sandler 37^th Annual Healthcare Conference and the Evercore ISI 8^th Annual HealthCONx Conference will be available on the Events and Presentations section of the Company’s website. A replay of the webcasts will remain archived for up to 30 days following the presentation date.

About SL-325

SL-325 is a potential first-in-class Death Receptor 3 (DR3) blocking antibody designed to achieve a complete and durable blockade of the clinically validated DR3/TL1A pathway. Shattuck’s preclinical studies demonstrate high affinity binding and superior activity over TL1A antibodies and offer a data-driven rationale for targeting the TNF receptor, DR3, versus its ligand, TL1A. SL-325 is a fully Fc-silenced humanized immunoglobin G monoclonal antibody with a favorable safety profile in non-human primates, currently being evaluated in a Phase 1 clinical trial.

About Shattuck Labs, Inc.
Shattuck Labs, Inc. (Nasdaq: STTK) is a clinical-stage biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. The Company is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. Shattuck’s expertise in protein engineering and the development of novel TNF receptor therapeutics come together in its lead program, SL-325, a potentially first-in-class DR3 antagonist antibody designed to achieve a more complete blockade of the clinically validated DR3/TL1A pathway. The Company has offices in both Austin, Texas and Durham, North Carolina. For more information, please visit: www.ShattuckLabs.com.

Investor & Media Contact:
Andrew R. Neill
Chief Financial Officer
Shattuck Labs, Inc.
InvestorRelations@shattucklabs.com

FAQ

When will Shattuck Labs (STTK) present at the Piper Sandler Healthcare Conference?

Shattuck Labs will present on Dec 2, 2025 at 10:10 AM ET at the Piper Sandler 37th Annual Healthcare Conference in New York.

Who will represent Shattuck Labs (STTK) at the December 2025 investor conferences?

CEO Taylor Schreiber, M.D., Ph.D. will present and participate in one-on-one meetings and a fireside chat.

What is the date and time for Shattuck Labs (STTK) fireside chat at Evercore ISI HealthCONx?

The fireside chat is scheduled for Dec 4, 2025 at 8:20 AM ET in Coral Gables, FL.

Will Shattuck Labs (STTK) webcasts be available after the live presentations?

Yes. Replays will be archived on the company’s Events and Presentations page for up to 30 days after each presentation.

How can investors access Shattuck Labs (STTK) presentation replays from December 2025?

Investors can access replays via the company’s Events and Presentations section on its website; webcast links are provided for each conference.